Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast
- PMID: 14693746
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast
Abstract
The biological mechanisms involved in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer are not fully understood. We previously have shown that the putative oncogene Aurora-A/STK15/BTAK, encoding a centrosome-associated kinase that regulates centrosomes and chromosome segregation, is amplified in human breast cancer. In this study, 37 archival breast tissue specimens of histologically confirmed DCIS lesions with adjacent invasive carcinoma and morphologically nonmalignant mammary ducts were analyzed immunohistochemically for expression of STK15. Statistically significant differences in overexpression of STK15 was found between invasive cancer and either nonmalignant mammary ducts (P < 0.0001) or DCIS lesions (P < 0.0005). Abnormalities in centrosome size and number was detected in the samples analyzed and 56% (14 of 25) of the cases also showed aneuploidy reflected in >2 signals of chromosome 3 and 17. Our data demonstrate that STK15 overexpression correlates with centrosome anomaly and aneuploidy in DCIS, and loss of STK15 overexpression is associated with progression of in situ to ductal invasive breast carcinoma.
Similar articles
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.Nat Genet. 1998 Oct;20(2):189-93. doi: 10.1038/2496. Nat Genet. 1998. PMID: 9771714
-
Breast carcinogenesis. Transition from hyperplasia to invasive lesions.Saudi Med J. 2005 Dec;26(12):1889-96. Saudi Med J. 2005. PMID: 16380768
-
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.Mod Pathol. 2002 Dec;15(12):1318-25. doi: 10.1097/01.MP.0000038462.62634.B1. Mod Pathol. 2002. PMID: 12481013
-
[Roles of Aurora-A in tumorigenesis and prognosis of breast cancer].Ai Zheng. 2009 Jun;28(6):668-72. Ai Zheng. 2009. PMID: 19635209 Review. Chinese.
Cited by
-
Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution.Oncol Lett. 2012 Jun;3(6):1237-1244. doi: 10.3892/ol.2012.660. Epub 2012 Mar 27. Oncol Lett. 2012. PMID: 22783425 Free PMC article.
-
Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice.Cancer Cell. 2007 Feb;11(2):161-73. doi: 10.1016/j.ccr.2006.11.025. Cancer Cell. 2007. PMID: 17292827 Free PMC article.
-
Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis.J Clin Pathol. 2007 Dec;60(12):1403-8. doi: 10.1136/jcp.2006.044305. Epub 2007 Feb 23. J Clin Pathol. 2007. PMID: 17322345 Free PMC article.
-
A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ.Clin Cancer Res. 2020 Jun 15;26(12):2898-2907. doi: 10.1158/1078-0432.CCR-19-1272. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937618 Free PMC article.
-
Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.Oncol Rep. 2020 May;43(5):1437-1450. doi: 10.3892/or.2020.7526. Epub 2020 Feb 28. Oncol Rep. 2020. PMID: 32323809 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous